The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...
The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...
Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients toward higher-priced insulin in order to reap ...
The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx ...
The Pharmaceutical Care Management Association, the industry’s trade group ... of special interests and designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback